Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks DATA + AI World Tour in Boston

Key Takeaways:

• Tevogen announced the news on September 10, 2025.
• Mittul Mehta, CIO and Head of Tevogen.AI, will speak on a panel.
• The Databricks DATA + AI World Tour takes place in Boston.
• Mehta’s panel focus is part of the Startup Forum.
• The session is scheduled for October 8, 2025.

Spotlight on Tevogen

Tevogen Bio Holdings Inc. (Nasdaq: TVGN) has released news celebrating the participation of its Chief Information Officer and Head of Tevogen.AI, Mittul Mehta, in the upcoming Databricks DATA + AI World Tour. According to the company’s announcement on September 10, 2025, Mehta’s inclusion in this major industry event signifies Tevogen’s growing presence in the fields of data science and AI-driven innovation.

Who Is Mittul Mehta?

As Tevogen’s CIO and Head of Tevogen.AI, Mehta is responsible for shaping the organization’s technical vision. This dual role underscores the firm’s technological ambitions and the significance it places on integrating AI solutions into its broader strategy. “Tevogen looks forward to the insights and industry perspectives gained through such forums,” the company stated in its release.

Databricks DATA + AI World Tour

The Databricks DATA + AI World Tour, taking place in Boston, has been widely recognized as a platform for showcasing advancements in data-driven technologies. Slated for October 8, 2025, this event brings together innovators, entrepreneurs, and leaders who specialize in artificial intelligence, cloud computing, and data analytics.

The Startup Forum Panel

A highlight of the Databricks DATA + AI World Tour is the Startup Forum, designed to spotlight emerging companies and leaders at the forefront of AI. Mehta’s participation is expected to introduce Tevogen’s perspective on leveraging data and AI, aligning with the conference’s focus on practical solutions for the modern tech industry.

Looking Ahead

Tevogen’s emphasis on AI and data-driven approaches reflects its broader mission to stay at the cutting edge of innovation. By speaking on this panel, Mehta will share how the firm envisions harnessing AI’s potential to advance its objectives. With the event just around the corner, Tevogen remains poised to demonstrate its commitment to exploring the transformative power of artificial intelligence in the biotech and healthcare sectors. “`